◆英語タイトル：Caladrius Biosciences Inc (CLBS) - Financial and Strategic SWOT Analysis Review
Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company that develops cell therapy products. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. The company’s lead product CLBS03 is an autologous ex vivo polyclonal T regulatory cell clinical phase 2 therapy used in the treatment of type 1 diabetes mellitus. Its other product candidates include CLBS12 used in the treatment of critical limb ischemia; and CLBS14 used in the treatment of coronary microvascular dysfunction. The company offers T regulatory technology and CD34 technology. Caladrius serves biotechnology, pharmaceutical and medical product companies, and academic research institutions. The company operates in Basking Ridge, Irvine and New York, the US. Caladrius is headquartered in Basking Ridge, New Jersey, the US.
Caladrius Biosciences Inc Key Recent Developments
Jan 07,2019: Caladrius Biosciences to Participate in Upcoming January Conferences
Nov 08,2018: Caladrius Biosciences appoints Cynthia Schwalm to Board of Directors
Nov 08,2018: Caladrius Biosciences reports 2018 third quarter financial results
Aug 09,2018: Caladrius Biosciences reports 2018 second quarter and first six months financial results
Jul 02,2018: Dr. Marilyn Glassberg Presents Findings on Stem Cell Treatments for Lung Diseases
This comprehensive SWOT profile of Caladrius Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Caladrius Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Caladrius Biosciences Inc – Key Information
Caladrius Biosciences Inc – Overview
Caladrius Biosciences Inc – Key Employees
Caladrius Biosciences Inc – Key Employee Biographies
Caladrius Biosciences Inc – Key Operational Heads
Caladrius Biosciences Inc – Major Products and Services
Caladrius Biosciences Inc – History
Caladrius Biosciences Inc – Company Statement
Caladrius Biosciences Inc – Locations And Subsidiaries
Caladrius Biosciences Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Caladrius Biosciences Inc – Business Description
Caladrius Biosciences Inc – Corporate Strategy
Caladrius Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Caladrius Biosciences Inc – Strengths
Caladrius Biosciences Inc – Weaknesses
Caladrius Biosciences Inc – Opportunities
Caladrius Biosciences Inc – Threats
Caladrius Biosciences Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Caladrius Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Caladrius Biosciences Inc, Key Information
Caladrius Biosciences Inc, Key Ratios
Caladrius Biosciences Inc, Share Data
Caladrius Biosciences Inc, Major Products and Services
Caladrius Biosciences Inc, History
Caladrius Biosciences Inc, Key Employees
Caladrius Biosciences Inc, Key Employee Biographies
Caladrius Biosciences Inc, Key Operational Heads
Caladrius Biosciences Inc, Other Locations
Caladrius Biosciences Inc, Subsidiaries
Caladrius Biosciences Inc, Key Manufacturing facilities
Caladrius Biosciences Inc, Key Competitors
Caladrius Biosciences Inc, SWOT Analysis
Caladrius Biosciences Inc, Ratios based on current share price
Caladrius Biosciences Inc, Annual Ratios
Caladrius Biosciences Inc, Interim Ratios
Capital Market Ratios
List of Figures
Caladrius Biosciences Inc, Performance Chart
Caladrius Biosciences Inc, Ratio Charts
| ★海外企業調査レポート[Caladrius Biosciences Inc (CLBS)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら